300233.SZ · 金城医药
China A-shares · RS rating 59 · As of 2026-10-14
| Price | 13.00 CNY |
|---|---|
| 1-day change | -1.5% |
| RS rating (overall / 1M / 3M / 12M) | 59 / 72 / 51 / 21 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 23 / 20 |
| Industry group (rank) | Chemicals-Basic (70) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -7.1% |
| Distance from 52-week high | +33.3% |
| Market cap (USD) | $791.1M |